Magnetic Resonance Assessment of Ejection Fraction Versus Echocardiography for Cardioverter-Defibrillator Implantation Eligibility

Código QR

Magnetic Resonance Assessment of Ejection Fraction Versus Echocardiography for Cardioverter-Defibrillator Implantation Eligibility

Background: The aim of this study was to investigate the potential impact of performing two-dimensional echocardiography (2DE) compared to cardiovascular magnetic resonance (CMR) for left ventricular ejection fraction (LVEF) on implantable cardioverter defibrillator (ICD) eligibility. Methods: A pro...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Călin Schiau, Daniel-Corneliu Leucuța, Sorin Marian Dudea, Simona Manole
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	cardiovascular magnetic resonance echocardiography ejection fraction implantable cardioverter defibrillator nonischemic cardiomyopathy Biology (General) QH301-705.5
Acceso en línea:	https://doaj.org/article/f1f5653d5b384009b45dc0467c07d4c0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Mortality among ischemic and nonischemic heart failure patients with a primary implantable cardioverter‐defibrillator
por: Pil‐Sung Yang, et al.
Publicado: (2021)

Implantable cardioverter defibrillators: Uses, abuses, gains and complications
por: Weiwei Li, et al.
Publicado: (2017)

Wearable Cardioverter-Defibrillator Used as a Telemonitoring System in a Real-Life Heart Failure Unit Setting
por: Christian Blockhaus, et al.
Publicado: (2021)

Resilience, Cardiological Outcome, and Their Correlations With Anxious-Depressive Symptoms and Quality of Life in Patients With an Implantable Cardioverter Defibrillator
por: Celeste Isella, et al.
Publicado: (2021)

Can machine learning complement traditional medical device surveillance? A case-study of dual-chamber implantable cardioverter–defibrillators
por: Ross JS, et al.
Publicado: (2017)

Wearable Cardioverter–Defibrillator-Measured Step Count for the Surveillance of Physical Fitness during Cardiac Rehabilitation
por: Boldizsar Kovacs, et al.
Publicado: (2021)

Main air pollutants and ventricular arrhythmias in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis
por: Hong-Jie Yang, et al.
Publicado: (2017)

Evaluation of the Impact of a Chronic Total Coronary Occlusion on Ventricular Arrhythmias and Long‐Term Mortality in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter‐Defibrillator (the <styled-content style="fixed-case">eCTO</styled-content>py‐in‐<styled-content style="fixed-case">ICD</styled-content> Study)
por: Ivo M. van Dongen, et al.
Publicado: (2018)

Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study
por: Ettinger S, et al.
Publicado: (2017)

Absence of Obesity Paradox in All-Cause Mortality Among Chinese Patients With an Implantable Cardioverter Defibrillator: A Multicenter Cohort Study
por: Bin Zhou, et al.
Publicado: (2021)

Critical appraisal concerning “Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study”
por: Sperzel J, et al.
Publicado: (2018)

Risk Factors and Temporal Trends of Complications Associated With Transvenous Implantable Cardiac Defibrillator Leads
por: Jayanthi N. Koneru, et al.
Publicado: (2018)

Doppler Tisular: velocidad de desplazamiento miocárdico en sístole en pacientes con hipertensión arterial con fracción de eyección conservada
por: Galdames,Katia, et al.
Publicado: (2012)

Comments on the authors’ reply to the critical appraisal concerning “Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study”
por: Sperzel J, et al.
Publicado: (2018)

Visual versus fully automated assessment of left ventricular ejection fraction
por: Rami Mahmood Abazid, et al.
Publicado: (2018)

History and perspectives of the defibrillation
por: Georgy O. Isaev, et al.
Publicado: (2021)

Non-Invasive Assessment of Left Ventricle Ejection Fraction: Where Do We Stand?
por: Alessandra Scatteia, et al.
Publicado: (2021)

Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations
por: Dzhioeva O, et al.
Publicado: (2020)

Validation of the 2016 ASE/EACVI Guideline for Diastolic Dysfunction in Patients With Unexplained Dyspnea and a Preserved Left Ventricular Ejection Fraction
por: Arno A. van de Bovenkamp, et al.
Publicado: (2021)

A study of association between heart failure with preserved ejection fraction with hypertension and diabetes mellitus
por: Swapan Sarkar, et al.
Publicado: (2021)

The Practice of Deep Sedation in Electrophysiology and Cardiac Pacing Laboratories: Results of an Italian Survey Promoted by the AIAC (Italian Association of Arrhythmology and Cardiac Pacing)
por: Pietro Palmisano, et al.
Publicado: (2021)

Reticular telangiectatic erythema: case report and literature review
por: Bryce D. Buetler, et al.
Publicado: (2015)

The Prognostic Value of Lung Ultrasound in Patients With Newly Diagnosed Heart Failure With Preserved Ejection Fraction in the Ambulatory Setting
por: Blanka Morvai-Illés, et al.
Publicado: (2021)

A Universal New Definition of Heart Failure With Improved Ejection Fraction for Patients With Coronary Artery Disease
por: Haozhang Huang, et al.
Publicado: (2021)

Evaluation of potential underuse of cardiac resynchronization therapy for heart failure with reduced ejection fraction
por: Makoto Takano, et al.
Publicado: (2021)

Current status on the therapeutic strategies for heart failure and diabetic cardiomyopathy
por: Amy Hyein Kim, et al.
Publicado: (2022)

Interatrial shunt devices for heart failure with normal ejection fraction: a technology update
por: Cuthbert JJ, et al.
Publicado: (2017)

The effects of levosimendan on renal functions in open-heart surgery patients with a low ejection fraction
por: Süleyman Yazıcı, et al.
Publicado: (2021)

Continuous Electrical Monitoring in Patients with Arrhythmic Myocarditis: Insights from a Referral Center
por: Giovanni Peretto, et al.
Publicado: (2021)

Right Ventricular Endocardial Mapping and a Potential Arrhythmogenic Substrate in Cardiac Amyloidosis—Role of ICD
por: Aleksandra Liżewska-Springer, et al.
Publicado: (2021)

Cardiac Resynchronization Therapy: Who Benefits?
por: Jason S. Chinitz, et al.
Publicado: (2014)

TRICUSPID VALVE REGURGITATION IN PATIENTS UNDERGOING ENDOCARDIAL LEADS PLACEMENT
por: Muhammad Asad, et al.
Publicado: (2020)

Readmissions, Death and Its Associated Predictors in Heart Failure With Preserved Versus Reduced Ejection Fraction
por: Wan Ting Tay, et al.
Publicado: (2021)

Management of Hypertrophic Cardiomyopathy
por: Alan D. Enriquez, et al.
Publicado: (2014)

Assessment of Left Ventricular Function using a Two-Dimensional Speckle Tracking Echocardiography in Asymptomatic Survivors of Hodgkin’s Lymphoma in Long-Term Follow-Up
por: Mustafa Altınkaynak, et al.
Publicado: (2021)

Echocardiography

Clinical course and outcomes of chronic heart failure with preserved left ventricular ejection fraction in concomitant overweight and obesity with comorbid atrial fibrillation
por: P. P. Bidzilya, et al.
Publicado: (2021)

The influence of pre-hospital medication administration in ST-elevation myocardial infarction patients on left ventricular ejection fraction and intra-hospital death
por: Magdalena Żurowska-Wolak, et al.
Publicado: (2021)

COMPARISON OF HEMODYNAMIC STABILITY WITH CISATRACURIUM AND ATRACURIUM IN PATIENTS WITH LOW EJECTION FRACTION UNDERGOING CORONARY ARTERY BYPASS GRAFTING
por: Mehwish Naseer, et al.
Publicado: (2020)

Left ventricular noncompaction diagnosed following Graves′ disease
por: Habib Habib, et al.
Publicado: (2016)